Cognia

Cognia introduces proprietary ubiquitin database at drug discovery conference

Published in Oncology Business Week, July 23rd, 2006

Cognia Corp., a pioneer in developing and aggregating biological information, unveiled its first proprietary database, Cognia Catabolism, covering key regulatory proteins of the ubiquitin system at the "Ubiquitin in Drug Discovery and Development" Conference in June.

The database, named Cognia Catabolism because of the ubiquitin system's role in breaking down (catabolizing) cellular proteins, will contain expertly curated information found in the scientific literature to provide a comprehensive structured information resource on ubiquitin system molecules, their attributes and interactions.

"This will be an extremely important and widely used...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Oncology Business Week

Source: Oncology Business Week (2006-07-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry